Other tumor entities with occasional and mostly low-level arginase-1 immunostaining included clear cell carcinomas of the ovary, neuroendocrine tumors of the pancreas, mucinous and lobular carcinoma of the breast, cholangiocarcinoma, and colorectal adenocarcinoma. This evidence concerns the gene ARG1 and neoplasm.